When a US company finds itself with a pharmaceutical product that will cross the Atlantic for the first time, there’s a whole new world of requirements to meet. One of those requirements is to assign a Qualified Person for Pharmacovigilance – the QPPV.
Join Dr. Vineet Kacker, Managing Director of APCER Pharma and a QPPV for 14 years, as he shares what to expect when a QPPV is added to your drug safety organization. You’ll learn why incorporating the QPPV’s perspective is more of a paradigm shift than most companies expect.
View the Recording of the Live Webinar
Agenda
– Requirement for the QPPV
– Finding the Right QPPV
– Positioning the QPPV for Success
– Embracing the QPPV Perspective
– Authority the QPPV Requires
– What to expect and not to expect from a QPPV
– Q&A
About Your Webinar Leader
Vineet Kacker, PhD, has been a Qualified Person/Person Responsible for Pharmacovigilance for more than 14 years, first at Ranbaxy (UK) Limited and then at PSI NV (now part of Jubilant Life Sciences). Dr. Kacker currently serves as QPPV for several of APCER Pharma’s clients, leading the development and maintenance of global pharmacovigilance systems that stand up to regulatory scrutiny and advance patient safety.